EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Link Between Opioid Misuse and Suicidal Ideation Is Strongest Among Sexual Minorities

Katherine Musacchio Schafer, Rachel M. Schott, Julia C. Dodd, Jameson K. Hirsch

Journal of Clinical Psychology · 2026-12 · 82 (12) · 2040-2047

DOI: 10.1002/jclp.70217 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Opioid misuse and suicidal ideation (SI) are significant public health concerns in the United States, and incidence rates may be elevated among sexual minority people. We used data from the 2021 National Survey on Drug and Health (heterosexual, n = 39,647, lesbian/gay n = 1329, bisexual n = 3774) to investigate rates of opioid misuse and suicidal ideation (SI) across sexual identity groups. We found that opioid misuse (heterosexual, 3.0%, lesbian/gay, 5.2%; bisexual, 5.7%) and SI (heterosexual, 4.0%; lesbian/gay, 13%; bisexual, 23%) were highest among bisexual participants, followed by lesbian/gay participants, followed then by heterosexual participants. Further, opioid misuse and SI were associated across sexual identity groups (entire sample: r = 0.08, p < 0.001; heterosexual: r = 0.07, p < 0.001; lesbian/gay: r = 0.11, p < 0.001; bisexual: r = 0.082, p = 0.003). Notably, the association between opioid misuse and SI was strongest among sexual minority respondents. This work confirms a deleterious linkage between opioid misuse and SI and indicates that sexual minority participants were at greater risk for opioid misuse and SI as compared to heterosexual individuals. Clinicians should be cognizant of the risk of comorbid opioid misuse and SI in their sexual minority patients, as they develop and implement intervention strategies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →